[Al[18F]F]Fapi-74 — Drug Intelligence | 13 EU Trials

Filter these 13 trials by condition, phase, country and more.

Open in Search →

13 Registered trials

8 Recruiting

1 Completed trials

6 Sponsors

3 Countries

Phase III

Phase II/III

Phase II

Phase I/II

Phase III: 2 Phase II/III: 4 Phase II: 5 Phase I/II: 2

Indications tested

Pulmonary fibrosis 2 Adenocarcinoma gastric 1

Sponsors using this IMP

Turku University Hospital 4 UZ Leuven 3 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 2 St Antonius Hospital 2 Leids Universitair Medisch Centrum (LUMC) 1 Varsinais-Suomen hyvinvointialue 1

All trials

13 total

PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with… Not authorised

2023-503686-26-00 Phase I/II 1 country St Antonius Hospital
Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both? Pending

2024-511104-16-00 Phase II 1 country Turku University Hospital
The Expression of Fibroblast Activation Protein in Patients with Non-Small Cell Lung Cancer Patients Pending

2025-523965-97-00 Phase II 1 country Turku University Hospital
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Gastric Cancer Pending

2026-526494-42-00 Phase II 1 country Varsinais-Suomen hyvinvointialue
A novel fibroblast imaging biomarker and ultrahigh resolution PET to improve the diagnosis and follow-up of giant cell arteritis Recruiting

2025-523880-39-02 Phase II/III 1 country UZ Leuven
Prospective diagnostic performance of PET/CT using the novel fibroblast imaging tracer 18F-AlF-FAPI-74 versus standard of care 18F-FDG in in… Recruiting

2024-516464-28-00 Phase II/III 1 country UZ Leuven
(PLASTIC-3) [18F]FAPI-PET/CT and Laparoscopy in STagIng advanced gastric Cancer – a multicenter prospective study Recruiting

2024-513255-32-00 Phase II/III 1 country Leids Universitair Medisch Centrum (LUMC)
FAPIDO Recruiting

2024-512059-19-00 Phase II/III 1 country UZ Leuven
PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with… Recruiting

2023-503686-26-02 Phase I/II 1 country St Antonius Hospital
The effect of [18F]F-FAPI PET-CT on management in patients with potentially resectable biliary tract cancers: prospective multicenter study … Recruiting

2023-507938-24-00 Phase III 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer Recruiting

2024-510651-35-00 Phase II 1 country Turku University Hospital
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer Recruiting

2023-510208-39-00 Phase II 1 country Turku University Hospital
[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary origin Ended

2023-505592-69-00 Phase III 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Showing 1–13 of 13 trials

← All drugs A–Z